Prognostic factors of lymphoma patients after autologous stem cell transplantation

来源 :中华医学会第14次全国血液学学术会议 | 被引量 : 0次 | 上传用户:hualidewushi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Lymphoma is a group of lymphoid malignancies of multiple biologically heterogeneous subtypes.Hematopoietic stem cell transplantation(HSCT)is considered as a curable therapy for lymphoma.However,factors related to its prognosis remain unclear.Herein,we retrospectively reviewed eighty patients diagnosed with lymphoma and treated with autologus HSCT(Auto HSCT)between January 2006 and August 2012 in a single center.
其他文献
会议
会议
会议
The right dose of daunorubicin(DNR)for the treatment of newly diagnosed acute myeloid leukemia(AML)is uncertain.Previous trials have shown conflicting results concerning the efficacy of high or low do
会议
会议
会议
会议
会议
会议
会议